- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library
 |
 |
Lithocholic Acid (LCA) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-Lithocholic Acid (LCA) antibodies (anti-Lithocholic Acid, anti-LCA) and diagnostic hapten-carrier conjugates BSA-Lithocholic Acid (LCA), OVA-Lithocholic Acid (LCA), KLH-Lithocholic Acid (LCA) antigens for Liver diseases LCA detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to
Neurodegenerative diseases diagnostics
products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-SMT-LCA-Ag01 | BSA-Lithocholic Acid (LCA) | 756 |
| GMP-SMT-LCA-Ag02 | OVA-Lithocholic Acid (LCA) | 756 |
| GMP-SMT-LCA-Ab01 | Anti-human Lithocholic Acid (LCA) mouse monoclonal antibody (mAb) | 1953 |
| GMP-SMT-LCA-Ab02 | Anti-human Lithocholic Acid (LCA) human monoclonal antibody (mAb) | 1953 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Products | GMP-SMT-LCA-Ag01 |
| Product Name | BSA-Lithocholic Acid (LCA) |
| Target/Biomarker | Lithocholic Acid(LCA) |
| Expression platform | Synthetic |
| Bioactivity validation | Lithocholic Acid (LCA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. |
| Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Lithocholic Acid (LCA) / OVA-Lithocholic Acid (LCA) is Synthetic. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-SMT-LCA-Ag02 |
| Product Name | OVA-Lithocholic Acid (LCA) |
| Target/Biomarker | Lithocholic Acid(LCA) |
| Expression platform | Synthetic |
| Bioactivity validation | Lithocholic Acid (LCA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. |
| Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Lithocholic Acid (LCA) / OVA-Lithocholic Acid (LCA) is Synthetic. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-SMT-LCA-Ab01 |
| Product Name | Anti-human Lithocholic Acid (LCA) mouse monoclonal antibody (mAb) |
| Target/Biomarker | Lithocholic Acid(LCA) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Human Lithocholic Acid (LCA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Lithocholic Acid (LCA) antibodies in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human Lithocholic Acid (LCA) monoclonal antibody (mAb) is a monoclonal antibody produced by hybridoma technology. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-SMT-LCA-Ab02 |
| Product Name | Anti-human Lithocholic Acid (LCA) human monoclonal antibody (mAb) |
| Target/Biomarker | Lithocholic Acid(LCA) |
| Expression platform | CHO |
| Isotypes | Human IgG1 |
| Bioactivity validation | Human Lithocholic Acid (LCA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Lithocholic Acid (LCA) antibodies in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human Lithocholic Acid (LCA) monoclonal antibody (mAb) is a monoclonal antibody produced by hybridoma technology. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Lithocholic acid, also known as 3
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments
No comments yet.